参考文献/References:
1 Mitchell J,Parangi S.The thyroid incidentaloma:an increasingly frequent consequence of radiologic imaging.Semin Ultrasound CT MR,2005,26(1):37-46.
2 Lin JD,Chao TC,Huang BY,et al.Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology.Thyroid,2005,15(7):708-717.
3 Ross DS.Nonpalpable thyroid nodules-managing an epidemic.J Clin Endocrinol Metab,2002,87(5):1938-1940.
4 Leenhardt L,Hejblum G.Franc B,et al.Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules.J Clin Endocrinol Metab,1999,84(1):24-28.
5 Topliss D.Thyroid incidentaloma:the ignorant in pursuit of the impalpable.Clin Endocrinol (Oxf),2004,60(1):18-20.
6 Mary Ann Liebert.Why thyroid cancer.Thytoid,2005,(4):303-304.
7 Wolf G,Aigner RM,Schaffler G,et al.Pathology results in [18F] fluorodeoxyglucose positron emission tomography of the thyroid gland,Nucl Med Commun,2003,24(12):1225-1230.
8 Kim TY,Kim WB,Ryu JS,et al.18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients:high prevalence of malignancy in thyroid PET incidentaloma.Laryngoscope,2005,115 (6):1074-1078.
9 Van den Bruel A,Maes A,De Potter T,et al.Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma.J Clin Endocrinol Metab,2002,87 (4):1517-1520.
10 Kang KW,Kim SK,Kang HS,et al.Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects.J Clin Endocrinol Metab,2003,88(9):4100-4104.
11 Cohen MS,Arslan N,Dehdashti F,et al.Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.Surgery,2001,130(6):941-946.
12 Chen YK,Ding HJ,Chen KT,et al.Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-Fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects.Anticancer Res,2005,25(2B):1421-1426.
13 Ylagan LR,Farkas T,Dehner LP.Fine needle aspiration of the thyroid:a cytohistologic correlation and study of discrepant cases.Thyroid,2004,14(1):35-41.
14 Wang W,Larson SM,Fazzari M,et al.Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.J Clin Endocrinol Metab,2000,85(3):1107-1113.
15 Kresnik E,Gallowitsch HJ,Mikosch P,et al.Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area.Surgery,2003,133(3):294-299.
相似文献/References:
[1]李盼丽,宋少莉.碘难治性分化型甲状腺癌靶向药物治疗进展[J].国际放射医学核医学杂志,2016,40(3):202.[doi:10.3760/cma.j.issn.1673-4114.2016.03.009]
Li Panli,Song Shaoli.Radioactive iodine refractory differentiated thyroid cancer targeted therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):202.[doi:10.3760/cma.j.issn.1673-4114.2016.03.009]
[2]杨珂,唐波,于夕荣,等.甲状腺癌131i治疗病房的辐射屏蔽计算与评价[J].国际放射医学核医学杂志,2015,39(5):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
yang ke,tang bo,yu xirong,et al.shielding calculation and assessment in 131i therapy for thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
[3]陈立,陈跃.分化型甲状腺癌骨转移诊断及疗效评价的核素显像研究进展[J].国际放射医学核医学杂志,2016,40(6):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
Chen Li,Chen Yue.Diagnosis and evaluation of curative effect progress of radionuclide imaging methods in differentiated thyroid cancer of bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
[4]刘斌,潘明志.BRAF基因突变对甲状腺乳头状癌诊治价值的研究进展[J].国际放射医学核医学杂志,2015,39(2):154.[doi:10.3760/cma.j.issn.1673-4114.2015.02.011]
Liu Bin,Pan Mingzhi.Advances in value of BRAF gene mutation on the diagnosis and treatment of papillary thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):154.[doi:10.3760/cma.j.issn.1673-4114.2015.02.011]
[5]胡斌,王锦锋,毛秋粉.18F-FDG PET/CT显像在Tg阳性131I全身显像阴性的分化型甲状腺癌患者中的应用价值[J].国际放射医学核医学杂志,2015,39(3):242.[doi:10.3760/cma.j.issn.1673-4114.2015.03.012]
Hu Bin,Wang Jinfeng,Mao Qiufen.The application value of 18F-FDG PET/CT in patients with differentiated thyroid cancer of high thyroglobulin level and negative 131I whole body scan[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):242.[doi:10.3760/cma.j.issn.1673-4114.2015.03.012]
[6]刘鹏杰,唐铭,邓智勇,等.131I治疗儿童分化型甲状腺癌期间出现低钙血症伴癫痫发作一例[J].国际放射医学核医学杂志,2015,39(4):352.[doi:10.3760/cma.j.issn.1673-4114.2015.04.017]
[7]寇莹,刘建中,郝新忠,等.甲状腺癌131I治疗后全身扫描盆腔浓聚131I的临床分析[J].国际放射医学核医学杂志,2014,38(1):15.[doi:10.3760/cma.j.issn 1673-4114.2014.01.004]
Kou Ying,Liu Jianzhong,Hao Xinzhong,et al.Analysis of pelvic 131I uptake after 131I whole body scan in patients with thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(3):15.[doi:10.3760/cma.j.issn 1673-4114.2014.01.004]
[8]李敬彦,蒋宁一.分化型甲状腺癌术后131I清甲治疗方法的相关问题[J].国际放射医学核医学杂志,2014,38(1):42.[doi:10.3760/cma.j.issn 1673-4114.2014.01.009]
Li Jingyan,Jiang Ningyi.Issues related to radioactive iodine ablation in patients with differentiated thyroid carcinoma under-going thyroid surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(3):42.[doi:10.3760/cma.j.issn 1673-4114.2014.01.009]
[9]马春旭,袁卫红.甲状腺结节影像学诊断研究进展[J].国际放射医学核医学杂志,2014,38(1):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]
Ma Chunxu,Yuan Weihong.Advanced research on imaging diagnosis of thyroid nodule[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(3):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]
[10]成钊汀,谭建.分化型甲状腺癌术后患者131I治疗的辐射剂量与防护[J].国际放射医学核医学杂志,2014,38(2):110.[doi:10.3760/cma.j.issn.1673-4114.2014.02.010]
Cheng Zhaoting,Tan Jian.Radiation dose and protection of differentiated thyroid carcinoma postoperative patients with 131I treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(3):110.[doi:10.3760/cma.j.issn.1673-4114.2014.02.010]
[11]惠金子,赵德善.Tg、TgAb及TSH在分化型甲状腺癌术前的预测分析[J].国际放射医学核医学杂志,2015,39(2):110.[doi:10.3760/cma.j.issn.1673-4114.2015.02.002]
Hui Jinzi,Zhao Deshan.The prediction of risk of differentiated thyroid carcinoma with preoperative serum thyroid stimulating hormone, thyrogiobulin and antithyroglobulin antibody[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):110.[doi:10.3760/cma.j.issn.1673-4114.2015.02.002]
[12]龙再颖,曲新艳,单英丽.99Tcm-MIBI显像对甲状腺结节良恶性鉴别诊断价值的研究[J].国际放射医学核医学杂志,2010,34(2):80.[doi:10.3760/cma.j.issn.1673-4114.2010.02.004]
LONG Zai-ying,QU Xin-yan,SHAN Ying-li.The diagnostic value of 99Tcm-MIBI imaging to benign and malignant thyroid lesions[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(3):80.[doi:10.3760/cma.j.issn.1673-4114.2010.02.004]
[13]胡旻,刘雅洁,许小飞,等.99Tcm-MIBI动态血流灌注显像和双时相核素显像对甲状腺冷结节良恶性的诊断价值研究[J].国际放射医学核医学杂志,2010,34(3):174.
HU Min,LIU Ya-jie,XU Xiao-fei,et al.Study on the diagnostic value of 99Tcm-MIBI dynamic blood flow perfusion imaging and double-phase radionuclide imaging in benign and malignant cold thyroid nodules[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(3):174.
[14]杨帆,袁卫红.放射性核素显像鉴别甲状腺“冷结节”良恶性的研究进展[J].国际放射医学核医学杂志,2009,33(1):33.[doi:10.3760/cma.j.issn.1673-4114.2009.01.033]
YANG Fan,YUAN Wei-hong.Study progress of nuclide imaging in the differential diagnosis of nonfunctional cold thyroid nodules[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(3):33.[doi:10.3760/cma.j.issn.1673-4114.2009.01.033]